Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S1473-3099(24)00672-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Re-emergence of Oropouche virus between 2023 and 2024 in Brazil: an observational epidemiological study.
Lancet Infect Dis
October 2024
Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY, USA. Electronic address:
Article Synopsis
- The study explores the resurgence of Oropouche fever in Brazil from 2023 to 2024, focusing on virological factors influencing the outbreak after decades of sporadic cases.
- Researchers gathered data from various sources, analyzed serum samples from patients and previously infected individuals, and performed molecular tests to understand the virus's characteristics and behavior.
- The findings showed an extraordinary spike in cases in 2024, with over 8,600 confirmed incidents, highlighting the virus's widespread distribution across all regions of Brazil.
Re-emergence of Oropouche virus in Brazil and Latin America.
Lancet Infect Dis
October 2024
Institute of Virology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; German Centre for Infection Research (DZIF), associated partner Charité-Universitätsmedizin Berlin, Berlin, Germany.
(Re-)Emergence of Oropouche Virus (OROV) Infections: Systematic Review and Meta-Analysis of Observational Studies.
Viruses
September 2024
Department of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy.
Oropouche Virus (OROV; genus of Orthobunyavirus) is the causal agent of Oropouche Fever (OF). Due to the lack of specific signs and symptoms and the limited availability of diagnostic tests, the actual epidemiology of OROV infections and OF has been extensively disputed. In this systematic review with meta-analysis, a literature search was carried out in PubMed, Scopus, EMBASE, and MedRxiv in order to retrieve relevant articles on the documented occurrence of OROV infections.
View Article and Find Full Text PDFReplication Kinetics of a Candidate Live-Attenuated Vaccine for Cache Valley Virus in .
Vector Borne Zoonotic Dis
November 2022
Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA.
The emergence or re-emergence of several orthobunyaviruses (order: ; family: ), including Cache Valley virus (CVV) and Oropouche virus, warrants the development and evaluation of candidate live-attenuated vaccines (LAVs). Ideally, these vaccines would elicit long-lasting immunity with one single immunization. Since the deletion of two virulence factors, NSs and NSm, has been shown to attenuate the virulence phenotype of orthobunyaviruses, phleboviruses, and nairoviruses, genetic manipulation of the viral genome is considered an effective strategy for the rational design of candidate LAVs for bunyaviruses across multiple families.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!